Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 21 matching records.
21 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
Automated Manufacturing Processes and Platforms for Large-scale Production of Clinical-grade Mesenchymal Stem/ Stromal Cells
Narrative Review on Immune Modulation, published in Stem Cell Rev Rep (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Rev Rep28 citations - Level BClinical TrialPubMed
A Narrative Review on Manufacturing Methods Employed in the Production of Mesenchymal Stromal Cells for Knee Osteoarthritis Therapy.
Clinical Trial on Knee Osteoarthritis, Osteoarthritis, Immune Modulation, published in Biomedicines (2025) — summary generated from the PubMed abstract.
- 2025
Biomedicines1 citations - Level DLaboratory StudyEurope PMC
Generation of Current Good Manufacturing Practices-Grade Mesenchymal Stromal Cell-Derived Extracellular Vesicles Using Automated Bioreactors
Laboratory Study, published in Biology (Basel) (2025) — summary generated from the PubMed abstract.
- 2025
Biology (Basel)27 citations - Level DAnimal StudyPubMed
Manufacturing, quality control, and GLP-grade preclinical study of nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles.
Animal Study on Chronic Inflammation, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther - Level BClinical TrialPubMed
Biological differences between adult and perinatal human mesenchymal stromal cells and their impact on the manufacturing processes.
Clinical Trial, published in Cytotherapy (2024) — summary generated from the PubMed abstract.
- 2024
Cytotherapy - Level DAnimal StudyPubMed
Harmonised culture procedures minimise but do not eliminate mesenchymal stromal cell donor and tissue variability in a decentralised multicentre manufacturing approach.
Animal Study on Immune Modulation, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther24 citations - Level DAnimal StudyEurope PMC
Three-Dimensional Bioprinted Controlled Release Scaffold Containing Mesenchymal Stem/Stromal Lyosecretome for Bone Regeneration: Sterile Manufacturing and In Vitro Biological Efficacy
Animal Study, published in Biomedicines (2022) — summary generated from the PubMed abstract.
- 2022
Biomedicines11 citations - Level DNarrative ReviewEurope PMC
Manufacturing Mesenchymal Stromal Cells for the Treatment of Osteoarthritis in Canine Patients: Challenges and Recommendations
Narrative Review on Osteoarthritis, Ligament Injury, Immune Modulation, published in Front Vet Sci (2022) — summary generated from the PubMed abstract.
- 2022
Front Vet Sci24 citations - Level DNarrative ReviewPubMed
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome.
Narrative Review on Immune Modulation, published in Front Immunol (2022) — summary generated from the PubMed abstract.
- 2022
Front Immunol102 citations - Level BClinical TrialEurope PMC
Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing
Clinical Trial on Immune Modulation, published in Front Cell Dev Biol (2021) — summary generated from the PubMed abstract.
- 2021
Front Cell Dev Biol36 citations - Level DLaboratory StudyEurope PMC
Current good manufacturing practice considerations for mesenchymal stromal cells as therapeutic agents
Laboratory Study, published in Biomater Biosyst (2021) — summary generated from the PubMed abstract.
- 2021
Biomater Biosyst34 citations - Level CCohort StudyPubMed
Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Cohort Study on Immune Modulation, published in Cytotherapy (2020) — summary generated from the PubMed abstract.
- 2020
Cytotherapy - Level DLaboratory StudyPubMed
Scalable Manufacturing of Human Mesenchymal Stromal Cells in the Vertical-Wheel Bioreactor System: An Experimental and Economic Approach.
Laboratory Study with a reported sample of 3, published in Biotechnol J (2019) — summary generated from the PubMed abstract.
- 2019
- n = 3
Biotechnol J - Level BClinical TrialEurope PMC
Metabolism in Human Mesenchymal Stromal Cells: A Missing Link Between hMSC Biomanufacturing and Therapy?
Clinical Trial on Immune Modulation, published in Front Immunol (2019) — summary generated from the PubMed abstract.
- 2019
Front Immunol77 citations - Level DLaboratory StudyPubMed
Clinical-Grade Manufacturing of Therapeutic Human Mesenchymal Stem/Stromal Cells in Microcarrier-Based Culture Systems.
Laboratory Study, published in Methods Mol Biol (2016) — summary generated from the PubMed abstract.
- 2016
Methods Mol Biol - Level CCohort StudyPubMed
Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production.
Cohort Study on Knee Osteoarthritis, Osteoarthritis, published in Stem Cell Res Ther (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cell Res Ther133 citations - Level BClinical TrialEurope PMC
Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices
Clinical Trial on Immune Modulation, published in Transfusion (2014) — summary generated from the PubMed abstract.
- 2014
Transfusion299 citations - Level BClinical TrialPubMed
Manufacturing and use of human placenta-derived mesenchymal stromal cells for phase I clinical trials: establishment and evaluation of a protocol.
Clinical Trial on Tendon Injury, published in Vojnosanit Pregl (2014) — summary generated from the PubMed abstract.
- 2014
Vojnosanit Pregl - Level DAnimal StudyPubMed
Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls.
Animal Study on Immune Modulation, published in Stem Cells Dev (2013) — summary generated from the PubMed abstract.
- 2013
Stem Cells Dev143 citations - Level DNarrative ReviewEurope PMC
Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review
Narrative Review on Face & Skin, published in Stem Cell Res Ther (2013) — summary generated from the PubMed abstract.
- 2013
Stem Cell Res Ther127 citations - Level BClinical TrialEurope PMC
Translating research into clinical scale manufacturing of mesenchymal stromal cells
Clinical Trial, published in Stem Cells Int (2011) — summary generated from the PubMed abstract.
- 2011
Stem Cells Int27 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406